CN104667143A - Traditional Chinese medicine decoction for treating coronary heart disease - Google Patents
Traditional Chinese medicine decoction for treating coronary heart disease Download PDFInfo
- Publication number
- CN104667143A CN104667143A CN201310610112.4A CN201310610112A CN104667143A CN 104667143 A CN104667143 A CN 104667143A CN 201310610112 A CN201310610112 A CN 201310610112A CN 104667143 A CN104667143 A CN 104667143A
- Authority
- CN
- China
- Prior art keywords
- radix
- heart disease
- coronary heart
- chinese medicine
- mentioned component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine decoction for treating a coronary heart disease, belongs to the technical field of traditional herb pharmaceutic preparations of uncertain structures, and particularly relates to the traditional Chinese medicine decoction for treating the coronary heart disease. The traditional Chinese medicine decoction for treating the coronary heart disease is low in cost, good in treatment effect, capable of being taken for a long time and free of toxic and side effects. The traditional Chinese medicine decoction comprises, by weight, 20-30 g of fructus evodiae, 20-30 g of lignum dalbergiae odoriferae, 20-30 g of phemeranthus, 20-30 g of polygonum multiflorum, 20-30 g of the root of red-rooted salvia, 20-30 g of curcuma aromatica, 20-30 g of safflower carthamus, 25-35 g of radix ophiopogonis, 25-35 g of schisandra chinensis, 25-35 g of black soya beans, 25-35 g of the root of kudzu vine, 25-35 g of folium ginkgo, 25-35 g of hawthorns, 25-35 g of Chinese yam, 25-35 g of pseudo-ginseng, 30-40 g of the fruit of Chinese wolfberry, 30-40 g of peach kernels, 30-40 g of platycodon grandiflorum, 30-40 g of liquorice, 30-40 g of sophora flowers, 30-40 g of semen cassiae and 30-40 g of anise.
Description
Technical field
the invention belongs to the technical field of medicine not determining structure of traditional herbal medicines, specifically, relate to a kind of Chinese medicine decoction being used for the treatment of coronary heart disease.
Background technology
coronary heart disease, full name is coronary atherosclerotic heart disease, and coronary heart disease is modal heart disease.At western developed countries such as the U.S., coronary heart disease causes dead first killer, and its sickness rate is about 5%, namely namely has 1 people to suffer from coronary heart disease in every 20 people.Update shows, and China's cardiovascular patient prevalence is in lasting ascent stage, reaches 2.3 hundred million before ill total number, on average just has 1 people to suffer from heart disease in every 5 adults.The patient that cardiovascular diseases's disease is died from the whole nation every year has 3,500,000.
heart is mainly made up of cardiac muscle, and coronary artery is responsible for blood supply of cardiac muscle.Cholesterol and other material can at blood vessel wall inner side formation of deposits specklees, make coronary atherosclerosis and narrow.After acquiring a certain degree, blood supply of cardiac muscle will reduce, thus causes chest pain, symptom or the myocardial infarction such as uncomfortable in chest.Most heart infarction is because thrombosis makes blood vessel block completely suddenly, causes permanent lesion to cardiac muscle.Long-term coronary heart disease also can make myocardial contraction decline and cause heart failure, and can cause arrhythmia.Coronary heart disease be a process slowly, be formed to from plaque within blood vessels and occur myocardial ischemia symptom, usually need through more than 10 ~ 20 years.But be difficult to be found without any symptom because early stage, and once occur that the symptom state of an illness may very seriously or cause damage to health.
coronary heart disease is the illness because causing a disease more than, the danger affecting incidence of coronary heart disease is present in our daily life, be closely related with life style, these risk factors, all can increase the chance that we obtain coronary heart disease, mainly comprise: (1) age and sex: after 40 years old, Incidence of CHD raises, and before female menopausal, sickness rate is lower than male, equal with male after menopause.(2) hyperlipemia: except the age, lipid metabolic disorder is the most important predictive factors of coronary heart disease.T-CHOL (TC) and low-density lipoprotein cholesterol (LDLC) also exist close relationship between level and the danger of coronary event.LDLC level often raises 1%, then the danger suffering from coronary heart disease increases 2-3%.Triglyceride (TG) is the independentpredictor of coronary heart disease, often with low HDL C and impaired glucose tolerance, is also the risk factor of coronary heart disease both rear.(3) hypertension: the formation and development of hypertension and coronary atherosclerosis is in close relations.Systolic blood pressure ratio diastolic blood pressure more can predict coronary event.The diastolic blood pressure of the systolic blood pressure ratio 90-94mmhg of 140-149mmhg more can increase the danger of coronary heart disease death.(4) smoking: smoking has many side effect to body, these side effect cause due to nicotine contained in smog, nicotine, carbon monoxide.Smoking is the important risk factor of coronary heart disease, there is obvious consumption-reaction relation between coronary heart disease and smoking.(5) diabetes: coronary heart disease is the primary cause of the death of teenage diabetics, and coronary heart disease accounts for nearly 80% of all causes of death of diabetic and admission rate.(6) obesity: the primary risk factor being clearly coronary heart disease, can increase coronary heart disease death rate.Obesity is defined as Body Mass Index (BMI=body weight (kg)/height square (m
2
)) at male >=27.8, women >=27.3.BMI and TC, TG increase, and HDL-C declines and is proportionate.(7) sitting life style: do not like that the generation of the human coronary heart disease moved and mortality prediction will double.(8) inherited genetic factors: study verified, the generation of coronary heart disease seemingly has familial, namely in kinsfolk or the relative that have relationship by blood, before 60 years old, there occurs myocardial infarction if having, that kinsfolk just has the tendency easily suffered from a heart complaint.
the large therapy approach of coronary heart disease three comprises Drug therapy, interventional therapy and surgical intervention.Can not symptom management or the patient of coronary heart disease accident easily occurs to Drug therapy, can interventional therapy or coronary bypass surgery be carried out, to allevating angina pectoris, improve cardiac function successful, improve long-term prognosis also significant.But interventional therapy and surgical operation all exist costly with insoluble post-operative complication: such as postoperative restenosis, acute subacute stent thrombosis is formed, bypass surgery wound is large, Low output syndrome etc.Therefore, the optimum efficiency of Drug therapy should be given full play to, prevent aggravation, carry out again if desired getting involved or surgical operation, thus alleviate patient financial burden, avoid get involved and operation drawback.In addition, Western medicine often side effect is large, and for this chronic disease of coronary heart disease, the harm of long-term taking to health is well imagined.
Summary of the invention
the present invention is exactly for the problems referred to above, makes up the deficiencies in the prior art, provides that a kind of cost is lower, therapeutic effect good, can long-term taking the Chinese medicine decoction of the treatment coronary heart disease had no side effect.
for realizing above-mentioned purpose of the present invention, the present invention adopts following technical scheme.
the present invention is made up of following Chinese medicine ingredients: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 20 ~ 30g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 25 ~ 35g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 30 ~ 40g of mentioned component.
the preparation method of Chinese medicine composition of the present invention: by medicinal for above-mentioned raw materials water soaking 4 hours, after adding water, big fire was boiled, and then slow fire boils half an hour, boils 3 times altogether.By 3 institute's taking liquid filtered through gauze, be then concentrated into 150ml with big fire, cool rear subpackage 3 bottles, refrigerator storage.Mel 20g is accompanied each serving 30ml(), 3 times/day, decoction being taken warmly, serve on 6 ~ 9 months on an empty stomach.
compared with prior art beneficial effect of the present invention.
the Chinese medicine decoction that the present invention treats coronary heart disease adopts blood circulation promoting and blood stasis dispelling, causing resuscitation with aromatic drugs, eliminating phlegm activates yang, obtain good curative effect and there is obvious Angiogensis activity, it, except promoting the angiogenesis of chick chorioallantoic membrane, can also promote bovine adrenal proliferation of microvascular endothelial cells and form luminal structure, increases myocardial vascular surface density, meanwhile, myocardial infarct size is significantly reduced.Further, can to the damage of antioxidant radical to heart, the integrity of protecting myocardial cell film, improves the diastolic function of Acute Ischemic Myocardium.With benefiting vital QI and blood, promoting the circulation of QI to relieve pain.
Detailed description of the invention
embodiment 1: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 20g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 30g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 35g of mentioned component.
embodiment 2: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 25g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 35g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 30g of mentioned component.
embodiment 3: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 30g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 25g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 40g of mentioned component.
case 1: Jiang, man, 69 years old.Patient before more than 10 year because of uncomfortable in chest, tachypnea is uncomfortable after examination in hospital, be diagnosed as coronary heart disease (ischemic cardiomyopathy), always in hospitalize, the state of an illness still recurrent exerbation in increasing the weight of trend year by year.In June, 2006, patient felt discomfort uncomfortable in chest again, and local check Color Sonography finds to expand whole-heartedly, left atrium 50mm, left ventricle 89mm, regional wall motion abnormality, slight pulmonary hypertension, and left heart function lowers; Electrocardiogram: myocardial ischemia, Left ventricular hypervoltage.Have a medical check-up: body temperature 36.6 DEG C, 108 beats/min, pulse, breathes 24 beats/min, blood pressure 90/60mmHg.Two pulmonary respiration sound is slightly thick, does not hear and dry moist rales.Apex beat is positioned at the outer 1cm of left side the 6th intercostal midclavicular line, and heart rate 108 beats/min, rule is neat, and pareordia is without obvious noise.Edema that two lower limb are slight.Patient starts the decoction taking the embodiment of the present invention 2, and follow up a case by regular visits to after half a year and seen just effect, outbreak uncomfortable in chest reduces, and tachypnea improves, and appetite takes a turn for the better, spiritedness.The left room 44mm of check Color Sonography, left room 79mm, EF39%.Continuous medication 3 months state of an illness are stablized always, do not check Color Sonography again.
case 2: discriminate certain, male, 58 years old.This patient is uncomfortable at burst on May 22nd, 2006 chest, and head is perspired and gone to see a doctor, and suddenly looking into coronary angiography has no narrow, electrocardiogram myocardial ischemia, and locality is diagnosed as coronary heart disease (ariant angina).Taking, Western medicine 7 months angina pectoris attackses are uncontrollable, have 2-4 angina pectoris attacks every day, about 30 seconds to 1 minute at every turn.Human health screening: body temperature 36.5 DEG C, 88 beats/min, pulse, breathes 16 beats/min, blood pressure 110/80mmHg.Two pulmonary respiration sound is clear, does not hear and dry moist rales.Apex beat is positioned at left side the 5th intercostal midclavicular line 0.5cm, heart rate 88 beats/min, and rule is neat, and pareordia is without obvious noise.Because therapeutic effect is not good enough, therefore patient starts in June, 2007 decoction taking the embodiment of the present invention 3, evident in efficacy, and angina pectoris in 4 months of taking medicine disappears.In December, 2007 is followed up a case by regular visits to through examination in hospital, and the indices such as blood fat, blood pressure, blood viscosity are all normal.Patient consumes in drug withdrawal in by the end of March, 2008 so far, did not have generation angina pectoris phenomenon after 9 months.
case 3: Pueraria lobota, women, 73 years old.Patient has hypertension history for many years, uncomfortable in chest, the chest pain of happening suddenly at the beginning of 2004, nervous, is diagnosed as coronary heart disease, heart failure, atrial fibrillation, conduction block through examination in hospital.Always at hospital's western medicine, DeGrain.Have a medical check-up: body temperature 36.1 DEG C, 51 beats/min, pulse, breathes 18 beats/min, blood pressure 100/70mmHg.Two pulmonary respiration sound is clear, does not hear and dry moist rales.Apex beat is positioned in the 5th intercostal midclavicular line of left side, heart rate 51 beats/min, and rule is neat, and pareordia is without obvious noise.In July, 2004 starts the decoction taking the embodiment of the present invention 1, and symptom takes a turn for the better very soon, and the mental status is also improved.Through taking this medicine 9 months until in April, 2005, health day by day recovers, sensation of oppression over the chest with shortness of breath transference cure, and check electrocardiogram is completely normal, and cardiac function also recovers normal.
case 4: Zhang, female, 58 years old.Hypertension, hyperlipidemia, blood viscosity height several years.Within 08 year, there is atrial fibrillation, myocardial ischemia, chest distress.In August, 08 acute cerebral infarction, left brain large area thromboembolism, right lower extremity hemiplegia, aphasis, once hospital rescue.Brain CT showed at that time: left half brain large area infraction, has hemorrhage on a small quantity; Color ultrasound: left room is large, heart failure; Electrocardiogram: atrial fibrillation, myocardial ischemia.Through taking the decoction 6 months of the embodiment of the present invention 1, recovery from illness.
case 5: Korea Spro, female, 87 years old.Within 2004, play uncomfortable in chest, weak, out of breath, the atrial fibrillation of sense, lower limbs edema, dyspnea, premature beat, left bundle branch block, electrocardiogram display atrial fibrillation, room are early.Be diagnosed as coronary heart disease, heart failure 4 grades.Start the decoction by the embodiment of the present invention 2 in August, 2005, serve on 2 years, atrial fibrillation reduces, and premature beat also takes a turn for the better to some extent, recognizes that old man is very spiritual in return visit, and each side recovers good.Still adhere to taking at present, premature beat is basic controlling, and atrial fibrillation also takes a turn for the better, and out of breath, weak, edema disappears.
Claims (4)
1. treat a Chinese medicine decoction for coronary heart disease, it is characterized in that: the present invention is made up of following Chinese medicine ingredients: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 20 ~ 30g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 25 ~ 35g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 30 ~ 40g of mentioned component.
2. the Chinese medicine decoction for the treatment of coronary heart disease as claimed in claim 1, is characterized in that: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 20g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 30g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 35g of mentioned component.
3. the Chinese medicine decoction for the treatment of coronary heart disease as claimed in claim 1, is characterized in that: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 25g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 35g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 30g of mentioned component.
4. the Chinese medicine decoction for the treatment of coronary heart disease as claimed in claim 1, is characterized in that: Fructus Evodiae, Lignum Dalbergiae Odoriferae, Herba portulacae, Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Curcumae, Flos Carthami, each 30g of mentioned component; Radix Ophiopogonis, Fructus Schisandrae Chinensis, Semen sojae atricolor, Radix Puerariae, Folium Ginkgo, Fructus Crataegi, Rhizoma Dioscoreae, Radix Notoginseng, each 25g of mentioned component; Fructus Lycii, Semen Persicae, Radix Platycodonis, Radix Glycyrrhizae, Flos Sophorae, Semen Cassiae, anise, each 40g of mentioned component.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310610112.4A CN104667143A (en) | 2013-11-27 | 2013-11-27 | Traditional Chinese medicine decoction for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310610112.4A CN104667143A (en) | 2013-11-27 | 2013-11-27 | Traditional Chinese medicine decoction for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104667143A true CN104667143A (en) | 2015-06-03 |
Family
ID=53303079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310610112.4A Pending CN104667143A (en) | 2013-11-27 | 2013-11-27 | Traditional Chinese medicine decoction for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104667143A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105477437A (en) * | 2016-01-26 | 2016-04-13 | 娄明晓 | Traditional Chinese medicine for treating ischemic cardiomyopathy and preparation method |
| CN106138618A (en) * | 2016-08-18 | 2016-11-23 | 徐伟俊 | One treats anginal Chinese and western medicinal composition and preparation method thereof |
-
2013
- 2013-11-27 CN CN201310610112.4A patent/CN104667143A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105477437A (en) * | 2016-01-26 | 2016-04-13 | 娄明晓 | Traditional Chinese medicine for treating ischemic cardiomyopathy and preparation method |
| CN106138618A (en) * | 2016-08-18 | 2016-11-23 | 徐伟俊 | One treats anginal Chinese and western medicinal composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103638462A (en) | Chinese medicinal liquor for treating coronary heart disease and preparation method thereof | |
| CN104667143A (en) | Traditional Chinese medicine decoction for treating coronary heart disease | |
| CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
| CN103908490A (en) | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof | |
| CN103751659B (en) | A kind of Chinese medicine preparation for treating coronary heart disease and preparation method | |
| CN105362797A (en) | Traditional Chinese medicine for treating myocarditis | |
| CN102580030A (en) | External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method | |
| CN105832978A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104873685A (en) | Medicine for treating coronary heart disease | |
| CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN102309561B (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
| CN109758497A (en) | For the Chinese medicine composition of chronic heart failure, drug and its preparation method and application | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103893483A (en) | Chinese medicinal composition for treating hyperthyroid heart disease | |
| CN105687961A (en) | Preparation method of granule for treating coronary artery atherosclerosis | |
| CN114796420B (en) | Traditional Chinese medicine composition for treating non-valvular atrial fibrillation as well as traditional Chinese medicine preparation and application thereof | |
| CN105168653A (en) | Traditional Chinese medicine composition used for treating coronary heart disease | |
| CN106177331A (en) | A kind of Chinese medicine treating hypertension | |
| CN106309659A (en) | Acupoint plaster for hypertension | |
| CN105535454A (en) | Medicine for treating diastolic cardiac dysfunction | |
| CN105560835A (en) | Medicine for treating chronic congestive heart failure | |
| CN105412672A (en) | Medicine for treating coronary atherosclerotic cardiopathy and chronic cardiac failure | |
| CN105596505A (en) | Traditional Chinese medicine for treating heart qi consumptive disease induced arrhythmia | |
| CN104524313A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150603 |